Dawn Langdon completed her training as a clinical psychologist at Oxford University and the Institute of Psychiatry, KCL. She worked as a clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery, Queen Square, London for sixteen years, obtaining a PhD on reasoning in organic brain syndromes from the Institute of Neurology, UCL and registration as both a neuropsychologist and a health psychologist.

She is now Professor of Neuropsychology and Director of Health and Medicine at Royal Holloway, University of London. She is also a Fellow of the British Psychological Society. She is neuropsychology lead on a number of multinational trials for the pharmaceutical industry. She has worked extensively on psychological aspects of MS, including measurement of cognition and it’s relation to pathology and other disease variables. She is also investigating how risks and benefits of MS medication are best communicated to patients, including a successful randomised control trial comparing the new protocol to consultation as usual. Another interest is how employment relates to cognition in MS.

She is co-chair of the BICAMS initiative (www.BICAMS.net), which has recommended a brief cognition tool for MS. There are currently 36 countries in the national validation pipeline, of whom

17 have published. The AAN have recommended BICAMS as part of its Quality Measurement Set for MS. Over 30 peer review journal articles recommend BICAMS for routine assessment. BICAMS has been used in a number of international pharma trials and also in other investigations of MS cognition relating to imaging, employment and everyday life tasks; in total 50 scientific papers have reported BICAMS results. Dawn Langdon has led on the development of IPAD BICAMS.

She is a frequent contributor to international scientific meetings and committees and is a Trustee of the UK MS Trust, with whom she has authored the MS cognition website www.stayingsmart.org.uk. She is co-chair of MS in the 21st Century.